- Home
- EWCZ vs CADL Comparison
EWCZ vs CADL Comparison
Compare EWCZ & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWCZ
- CADL
- Stock Information
- Founded
- EWCZ 2004
- CADL 1999
- Country
- EWCZ United States
- CADL United States
- Employees
- EWCZ N/A
- CADL N/A
- Industry
- EWCZ Package Goods/Cosmetics
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- EWCZ Consumer Discretionary
- CADL Health Care
- Exchange
- EWCZ Nasdaq
- CADL Nasdaq
- Market Cap
- EWCZ 300.3M
- CADL 306.4M
- IPO Year
- EWCZ 2021
- CADL 2021
- Fundamental
- Price
- EWCZ $4.22
- CADL $7.81
- Analyst Decision
- EWCZ Buy
- CADL Strong Buy
- Analyst Count
- EWCZ 7
- CADL 4
- Target Price
- EWCZ $6.07
- CADL $21.00
- AVG Volume (30 Days)
- EWCZ 708.0K
- CADL 890.2K
- Earning Date
- EWCZ 03-11-2025
- CADL 03-13-2025
- Dividend Yield
- EWCZ N/A
- CADL N/A
- EPS Growth
- EWCZ 29.60
- CADL N/A
- EPS
- EWCZ 0.22
- CADL N/A
- Revenue
- EWCZ $216,916,000.00
- CADL N/A
- Revenue This Year
- EWCZ $5.65
- CADL N/A
- Revenue Next Year
- EWCZ $4.11
- CADL N/A
- P/E Ratio
- EWCZ $18.67
- CADL N/A
- Revenue Growth
- EWCZ N/A
- CADL N/A
- 52 Week Low
- EWCZ $2.72
- CADL $1.45
- 52 Week High
- EWCZ $13.15
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- EWCZ 29.52
- CADL 46.96
- Support Level
- EWCZ $3.83
- CADL $8.03
- Resistance Level
- EWCZ $4.36
- CADL $8.69
- Average True Range (ATR)
- EWCZ 0.37
- CADL 0.54
- MACD
- EWCZ -0.01
- CADL -0.04
- Stochastic Oscillator
- EWCZ 49.83
- CADL 34.97
About EWCZ European Wax Center Inc.
European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.